Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 15026 - 15050 of 15636 in total

Autologous killer cell

Investigational

Autologous pancreatic islets

Autologous pancreatic islet therapy involves isolating the patient's own insulin-producing cells.
Investigational

Bifidobacterium spp.

Investigational

Lactobacillus brevis

Investigational

OSSM-007

OSSM-007 consists of interferon-gamma primed allogeneic mesenchymal stem cells.
Investigational

PA3-17

PA3-17 is CD7-directed chimeric antigen receptor (CAR) T-cell therapy.
Investigational

ETX101

ETX101 is a non-replicating recombinant adeno associated viral vector, serotype 9, designed to promote increased transcription of SCN1A gene.
Investigational

PBGM01

PBGM01 is a non-replicating recombinant adeno-associated virus serotype hu68 vector, which contains human GLB1 transgene encoding the galactosidase beta 1 enzyme.
Investigational

CTR-107

CTR-107 is a synthetic targeted growth factor. It is being investigated for the treatment of familial exudative vitreoretinopathy.
Investigational

Recombinant neuroglobin

Investigational

M1-c6v1

M1-c6v1 is a recombinant oncolytic virus.
Investigational

TSHA-102

TSHA-102 is a recombinant serotype 9 adeno-associated virus encoding a codon-optimized human MECP2 gene.
Investigational

ECT204

ECT204 is an autologous T-cell therapy whereby T cells are genetically modified to target tumor-specific antigens.
Investigational

ST266

ST266 is an amniotic membrane-derived cellular cytokine solution.
Investigational

VGB-R04

VGB-R04 is an adeno-associated viral vector delivering human FIX Padua gene.
Investigational

CTX130

CTX130 is an allogeneic CRISPR/Cas9-mediated genetically modified CAR T cell therapy targeting CD70 antigen.
Investigational

Allogeneic natural killer cells

Investigational

AVR-RD-05

AVR-RD-05 is a gene therapy comprising genetically modified autologous stem cells transduced ex vivo with a lentiviral vector encoding the human iduronate-2-sulfatase (IDS) enzyme. It is under investigation for the treatment of Hunter Syndrome (Mucopolysaccharidosis Type II, MPSII).
Investigational

MaaT013

MaaT013 is an allogeneic fecal microbiota therapy. It is being investigated for the treatment of Graft-Versus-Host Disease.
Investigational

ATIR101

ATIR101 is a haploidentical, naïve cell-enriched T-cell therapy.
Investigational

Allogeneic human pancreatic islets of Langerhans

Investigational

ssCART-19 cells

ssCART-19 cells consist of autologous anti-CD19 Chimeric Antigen Receptors (CAR)-T cells expressing a short hairpin RNA (shRNA) against interleukin-6 (IL-6).
Investigational

Epidermal Growth Factor Receptor variant III (EGFRvIII) chimeric antigen receptor T cells

Investigational

Autologous CD4+CD25hiFoxP3+regulatory T cells

Investigational

Avoplacel

Avoplacel (PLX-R18) is an allogeneic cell therapy under investigation for the treatment of acute radiation syndrome.
Investigational
Displaying drugs 15026 - 15050 of 15636 in total